Dopamine Agents (Dopaminergic Agents)

Subscribe to Selected New Research on Dopamine Agents

379 relevant articles (36 outcomes, 31 trials/studies) found for this Bio-Agent

Description: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Also Known As:

Dopaminergic Agents; Drugs, Dopaminergic; Dopamine Drugs; Dopaminergic Drugs; Agents, Dopamine; Agents, Dopaminergic; Drugs, Dopamine

Relationship Network

Bio-Agent Context: Research Results

Chemical Actions and Uses

Pharmacologic Actions: 50

Molecular Mechanisms of Pharmacological Action: 5

Neurotransmitter Agents: 5439

Dopamine Agents: 379

Dopamine Agonists: 1995

Dopamine Antagonists: 235

Dopamine Uptake Inhibitors: 17

Physiological Effects of Drugs: 1

Neurotransmitter Agents: 5439

Dopamine Agents: 379

Dopamine Agonists: 1995

Dopamine Antagonists: 235

Dopamine Uptake Inhibitors: 17

Experts

1.	Drago, F: 2 articles (04/2006 - 06/2002)
2.	Rampello, L: 2 articles (04/2006 - 06/2002)
3.	Gao, X: 2 articles (04/2001 - 10/2000)
4.	Wu, G: 2 articles (04/2001 - 10/2000)
5.	Zhang, Y: 2 articles (04/2001 - 10/2000)
6.	Zafonte, R D: 2 articles (02/2001 - 10/2000)
7.	Cullen, N: 2 articles (02/2001 - 10/2000)
8.	Lexell, J: 2 articles (02/2001 - 10/2000)
9.	Steiger, M: 1 article (01/2008)
10.	Gerlach, Manfred: 1 article (12/2007)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/01/2006 - "Although it is an undeniable fact that dopaminergic therapy has greatly improved the quality of life and prognosis of patients with Parkinson's disease, various and serious adverse events correlated to dopaminergic drugs are not uncommon" 08/01/2003 - "Electrophysiological studies in rats, monkeys and patients with Parkinson's disease have shown that power and coherence of low frequency oscillations in CST systems can be profoundly modulated by dopaminergic drugs" 06/01/2003 - "OBJECTIVE: To study the impact of the new pharmacological treatment strategies in Parkinson's disease by analysis of the sales of dopaminergic drugs in Sweden 1990-2001" 02/01/2008 - "The opposite is observed in Parkinson's disease, where the reduced autonomic activity induced by the illness is associated with a decreased frequency of vascular risk factors, and their occurrence is further reduced by the treatment with dopaminergic drugs." 01/01/2008 - "Degeneration of the dopaminergic system in Parkinson's disease and longstanding exposure to dopaminergic drugs may cause reward system malfunction" Get all the results and reference details, order at left...
2.	Dyskinesias (Dyskinesia) 04/01/2000 - "However, a variety of therapeutic strategies primarily related to the use of non-dopaminergic agents may be able to prevent dyskinesia from occurring, and the actions of neurotropic factors, such as glial-derived neurotropic factor, may be effective in reversing established involuntary movements." 08/01/2002 - "Mean dosage of dopaminergic drugs was reduced, but force overflow and dyskinesias were equally improved in 2 patients without a reduction" 09/01/2008 - "The subsequent response of the abnormal basal ganglia to dopaminergic drugs determines the manner and timing of dyskinesia expression" 07/01/2007 - "Chronic exposure to dopaminergic agents, however, supports onset of motor complications and dyskinesia in the long term" 01/01/2005 - "RESULTS: Several variables were demonstrated significantly to distinguish fallers: disease duration and severity; dyskinesias associated with the use of dopaminergic agents; freezing; postural instability; depression; fear of falling; impaired fine motor control and motor planning in the feet; decreased proximal strength and muscular endurance in the legs; and a higher level of disability" Get all the results and reference details, order at left...
3.	Restless Legs Syndrome (Restless Legs) 01/01/2007 - "Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS)" 09/01/2001 - "Dopaminergic agents are highly effective in treating restless legs syndrome, but side effects can be problematic" 12/10/2005 - "Restless Legs Syndrome (RLS) has become a well known disorder in the medical community in Switzerland within the last ten years, particularly since the official introduction of dopaminergic drugs as first line treatment" 11/01/2002 - "Several pieces of evidence suggest that a dopaminergic dysfunction might play a key role in the pathophysiology of restless legs syndrome (RLS), including the therapeutic effects of dopaminergic drugs and the results of several positron emission tomography and single photon emission computed tomography studies" 11/01/1990 - "The study showed that the relief of symptoms of restless legs syndrome by dopaminergic drugs does not wear off with the passage of time, that side effects are minimal even with long-term use, and that the dose needed to obtain relief may increase as well as decrease." Get all the results and reference details, order at left...
4.	Tremor (Tremors) 09/01/2004 - "The only important predictors of improvement in UPDRS part III motor scores were the baseline response to dopaminergic drugs (p = 0.015) and the presence of tremor (p = 0.027)" 02/26/2002 - "Although all dopaminergic drugs are effective in reducing tremor, no single drug has been shown to be clearly superior in the treatment of tremor" 03/01/1999 - "We found that anticholinergic and dopaminergic agents are both effective in reducing tremor in IPD, and there was no evidence for a selective anticholinergic responsiveness of parkinsonian tremor" 11/01/2003 - "Dopaminergic studies may have a limited clinical role in the diagnosis of patients who have symptoms that suggestive of PD yet do not respond to typical dopaminergic drugs, such as patients who have vascular parkinsonism or ET with mild resting tremor who may have normal dopaminergic innervation" 03/01/1996 - "With the exception of dopaminergic drugs in Parkinson's disease, drug effects in tremors are unpredictable and nonspecific" Get all the results and reference details, order at left...
5.	Hyperprolactinemia 12/01/2001 - "The treatment of hyperprolactinemia has greatly benefited from the generation of progressively more effective and selective dopaminergic drugs." 08/01/1992 - "The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia." 07/01/1991 - "Lastly, particular aspects are taken into consideration, such as the relationship between hyperprolactinemia and pregnancy, in the light of the most recent findings on the natural evolution of prolactinemia and the possibility of treatment using dopaminergic drugs." 01/01/1983 - "Dopaminergic agents in the treatment of hyperprolactinemia]" 10/01/2004 - "This, and the use of dopaminergic drugs, which normalize prolactin levels in male hyperprolactinemia, may be effective in reversing ED in these endocrine disorders." Get all the results and reference details, order at left...
122 Diseases and 379 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Levodopa (L Dopa)
2.	Prolactin
3.	Dopamine (Intropin)
4.	Dobutamine
5.	Antidepressive Agents (Antidepressants)
6.	Cholinergic Agents (Cholinergics)
7.	Epinephrine (Adrenaline)
8.	modafinil (armodafinil)
9.	Bromocriptine (Parlodel)
10.	Morphine (MS Contin)
171 Drugs and Important Bio-Agents and 188 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Transplants (Transplant)
3.	Deep Brain Stimulation
4.	Drug Therapy (Chemotherapy)
5.	Transplantation (Transplant Recipients)
13 Therapies and Procedures and 18 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>